Literature DB >> 28608928

Self-care management of type 1 diabetes has improved in Swedish schools according to children and adolescents.

Anna Bixo Ottosson1, Karin Åkesson2,3, Rosita Ilvered2, Gun Forsander4,5, Stefan Särnblad6,7.   

Abstract

AIM: Age-appropriate support for diabetes self-care is essential during school time, and we investigated the perceived quality of support children and adolescents received in 2015 and 2008.
METHODS: This national study was based on questionnaires answered by children and adolescents aged 6-15 years of age with type 1 diabetes attending schools or preschools in 2008 (n = 317) and 2015 (n = 570) and separate parental questionnaires. The subjects were recruited by Swedish paediatric diabetes units, with 41/44 taking part in 2008 and 41/42 in 2015.
RESULTS: Fewer participants said they were treated differently in school because of their diabetes in 2015 than 2008. The opportunity to perform insulin boluses and glucose monitoring in privacy increased (80% versus 88%; p < 0.05). Most (83%) adolescents aged 13-15 years were satisfied with the support they received, but levels were lower in girls (p < 0.05). More subjects had hypoglycaemia during school hours (84% versus 70%, p < 0.001), but hypoglycaemia support did not increase and was lower for adolescents than younger children (p < 0.001).
CONCLUSION: Children and adolescents received more support for type 1 diabetes in Swedish schools in 2015 than 2008, but more support is needed by girls and during hypoglycaemia. ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Hypoglycaemia, Schools; Questionnaires; Self-care; Type 1 diabetes

Mesh:

Year:  2017        PMID: 28608928     DOI: 10.1111/apa.13949

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  The impact of COVID-19 lockdown on glycaemic control and use of health services among children followed at a Danish diabetes clinic.

Authors:  Poul-Erik Kofoed; Signe Timm
Journal:  Acta Paediatr       Date:  2021-10-05       Impact factor: 4.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.